Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：102 Table Number：123
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Biopharmaceuticals market in this environment. In terms of revenue, this research report indicated that the global Biopharmaceuticals market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Biopharmaceuticals industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ????Roche aims at producing XX Biopharmaceuticals in 2020, with XX % production to take place in global market, ????Pfizer accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Biopharmaceuticals Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Biopharmaceuticals Market? Roche Pfizer Amgen Johnson & Johnson Eli Lilly Novartis AbbVie Novo Nordisk Sanofi-Aventis Merck ... Major Type of Biopharmaceuticals Covered in XYZResearch report: Monoclonal Antibodies Interferon Colony-Stimulating Factor Erythropoietin Growth Hormones Insulin Vaccines Others Application Segments Covered in XYZResearch Market Tumor Diabetes Hemophilia Cardiovascular Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Biopharmaceuticals Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Monoclonal Antibodies -Product Introduction and Major Manufacturers 1.1.2 Interferon -Product Introduction and Major Manufacturers 1.1.3 Colony-Stimulating Factor -Product Introduction and Major Manufacturers 1.1.4 Erythropoietin -Product Introduction and Major Manufacturers 1.1.5 Growth Hormones -Product Introduction and Major Manufacturers 1.1.6 Insulin -Product Introduction and Major Manufacturers 1.1.7 Vaccines -Product Introduction and Major Manufacturers 1.1.8 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Biopharmaceuticals Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Biopharmaceuticals Market 3.1.1 Top Companies leading Biopharmaceuticals Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Biopharmaceuticals Market 3.2.1 Top Companies leading Biopharmaceuticals Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Biopharmaceuticals Market 3.3.1 Top Companies leading Biopharmaceuticals Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Biopharmaceuticals Market 3.4.1 Top Companies leading Biopharmaceuticals Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Biopharmaceuticals Market 3.5.1 Top Companies leading Biopharmaceuticals Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Biopharmaceuticals Market 3.6.1 Top Companies leading Biopharmaceuticals Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Biopharmaceuticals Market 3.7.1 Top Companies leading Biopharmaceuticals Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Biopharmaceuticals Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Biopharmaceuticals Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Biopharmaceuticals Sales and Growth Rate (2021-2026) 5.2 Global Biopharmaceuticals Sales Value and Growth Rate (2021-2026) 6 Biopharmaceuticals Competitive Analysis 6.1 Roche 6.1.1 Roche Company Profiles 6.1.2 Roche Product Introduction 6.1.3 Roche Biopharmaceuticals Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Pfizer 6.2.1 Pfizer Company Profiles 6.2.2 Pfizer Product Introduction 6.2.3 Pfizer Biopharmaceuticals Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Amgen 6.3.1 Amgen Company Profiles 6.3.2 Amgen Product Introduction 6.3.3 Amgen Biopharmaceuticals Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Johnson & Johnson 6.4.1 Johnson & Johnson Company Profiles 6.4.2 Johnson & Johnson Product Introduction 6.4.3 Johnson & Johnson Biopharmaceuticals Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Eli Lilly 6.5.1 Eli Lilly Company Profiles 6.5.2 Eli Lilly Product Introduction 6.5.3 Eli Lilly Biopharmaceuticals Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Novartis 6.6.1 Novartis Company Profiles 6.6.2 Novartis Product Introduction 6.6.3 Novartis Biopharmaceuticals Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 AbbVie 6.7.1 AbbVie Company Profiles 6.7.2 AbbVie Product Introduction 6.7.3 AbbVie Biopharmaceuticals Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Novo Nordisk 6.8.1 Novo Nordisk Company Profiles 6.8.2 Novo Nordisk Product Introduction 6.8.3 Novo Nordisk Biopharmaceuticals Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Sanofi-Aventis 6.9.1 Sanofi-Aventis Company Profiles 6.9.2 Sanofi-Aventis Product Introduction 6.9.3 Sanofi-Aventis Biopharmaceuticals Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Merck 6.10.1 Merck Company Profiles 6.10.2 Merck Product Introduction 6.10.3 Merck Biopharmaceuticals Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Biopharmaceuticals Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Biopharmaceuticals Sales (K Unit) by Type (2015-2026) Figure Global Biopharmaceuticals Sales (K Unit) and Growth Rate (2015-2026) Figure Global Biopharmaceuticals Sales Market Share (%) by Type (2019 -2020) Table Global Biopharmaceuticals Sales Value (Million USD) by Type (2015-2026) Figure Global Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Biopharmaceuticals Sales Value Market Share (%) by Type (2019-2020) Table Global Biopharmaceuticals Sales (K Unit) by Application (2015-2026) Table China Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table China Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table China Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure China Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table China Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table China Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table China Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure China Biopharmaceuticals Sales (Unit) by Type (2015-2026) Table EU Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table EU Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table EU Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure EU Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table EU Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table EU Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure EU Biopharmaceuticals Sales (Unit) by Type (2015-2026) Table USA Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table USA Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table USA Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure USA Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table USA Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table USA Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure USA Biopharmaceuticals Sales (Unit) by Type (2015-2026) Table Japan Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table Japan Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table Japan Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table Japan Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table Japan Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure Japan Biopharmaceuticals Sales (Unit) by Type (2015-2026) Table India Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table India Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table India Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure India Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table India Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table India Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table India Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure India Biopharmaceuticals Sales (Unit) by Type (2015-2026) Table Southeast Asia Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table Southeast Asia Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table Southeast Asia Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure Southeast Asia Biopharmaceuticals Sales (Unit) by Type (2015-2026) Table South America Biopharmaceuticals Sales (K Unit) of Major Company (2015-2020) Table South America Biopharmaceuticals Sales Market Share of Major Company (2015-2020) Table South America Biopharmaceuticals Sales Value (Million USD) of Major Company (2015-2020) Figure South America Biopharmaceuticals Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Biopharmaceuticals Sales Value Share of Major Company (2015-2020) Table South America Biopharmaceuticals Price (USD/Unit), by Type (2019-2020) Table South America Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure South America Biopharmaceuticals Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Biopharmaceuticals Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Biopharmaceuticals Figure Cost Structure of Biopharmaceuticals in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Biopharmaceuticals Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Biopharmaceuticals Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table ????Roche Profiles Table ????Roche Biopharmaceuticals Product Introduction Table ????Roche Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Roche SWOT Analysis Table ????Pfizer Profiles Table ????Pfizer Biopharmaceuticals Product Introduction Table ????Pfizer Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Pfizer SWOT Analysis Table ????Amgen Profiles Table ????Amgen Biopharmaceuticals Product Introduction Table ????Amgen Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Amgen SWOT Analysis Table ????Johnson & Johnson Profiles Table ????Johnson & Johnson Biopharmaceuticals Product Introduction Table ????Johnson & Johnson Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Johnson & Johnson SWOT Analysis Table ????Eli Lilly Profiles Table ????Eli Lilly Biopharmaceuticals Product Introduction Table ????Eli Lilly Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Eli Lilly SWOT Analysis Table ????Novartis Profiles Table ????Novartis Biopharmaceuticals Product Introduction Table ????Novartis Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Novartis SWOT Analysis Table ????AbbVie Profiles Table ????AbbVie Biopharmaceuticals Product Introduction Table ????AbbVie Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????AbbVie SWOT Analysis Table ????Novo Nordisk Profiles Table ????Novo Nordisk Biopharmaceuticals Product Introduction Table ????Novo Nordisk Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Novo Nordisk SWOT Analysis Table ????Sanofi-Aventis Profiles Table ????Sanofi-Aventis Biopharmaceuticals Product Introduction Table ????Sanofi-Aventis Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Sanofi-Aventis SWOT Analysis Table ????Merck Profiles Table ????Merck Biopharmaceuticals Product Introduction Table ????Merck Biopharmaceuticals Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
